Rapport Therapeutics, Inc. RAPP Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Rapport Therapeutics, Inc.’s reported figures.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s invested capital?
- Rapport Therapeutics, Inc. (RAPP) reported invested capital of $404.26M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s invested capital changed year-over-year?
- Rapport Therapeutics, Inc.'s invested capital increased by 71.2% year-over-year, from $236.07M to $404.26M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s invested capital?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s invested capital has grown at a 117.6% compound annual growth rate (CAGR), from -$93.66M to $443.49M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).